Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Illidge

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
BMJ (Clinical Research Ed.)|June 4, 2015
Personalised approach to treating early Hodgkin's lymphomaTim Illidge
Hematological Oncology|June 19, 2013
XVII. Radiotherapy in early stage Hodgkin lymphomaTim Illidge
Blood|June 6, 2009
When is a predose a dose too much?Tim Illidge, Yong Du
Best Practice & Research. Clinical Haematology|June 11, 2011
Radioimmunotherapy in follicular lymphomaTim Illidge, Franck Morschhauser
Leukemia & Lymphoma|April 10, 2008
Current treatment approaches for diffuse large B-cell lymphomaTim Illidge, Shaun Tolan
Leukemia & Lymphoma|August 9, 2005
Anti-CD 40 monoclonal antibodyTom Geldart, Tim Illidge
Leukemia & Lymphoma|July 8, 2008
How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?Tim Illidge, Clara Chan
The Journal of Pharmacy and Pharmacology|July 23, 2008
New insights into the mechanisms of action of radioimmunotherapy in lymphomaAndrei Ivanov, Ruth Swann, Tim Illidge
The New England Journal of Medicine|July 23, 2015
PET-Directed Therapy for Hodgkin's LymphomaJohn Radford, Tim Illidge, Sally Barrington
Current Opinion in Urology|August 24, 2016
Immunotherapy with radiotherapy in urological malignanciesShaveta Mehta, Tim Illidge, Ananya Choudhury
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
BMJ (Clinical Research Ed.)|June 4, 2015
Personalised approach to treating early Hodgkin's lymphomaTim Illidge
Hematological Oncology|June 19, 2013
XVII. Radiotherapy in early stage Hodgkin lymphomaTim Illidge
Blood|June 6, 2009
When is a predose a dose too much?Tim Illidge, Yong Du
Best Practice & Research. Clinical Haematology|June 11, 2011
Radioimmunotherapy in follicular lymphomaTim Illidge, Franck Morschhauser
Leukemia & Lymphoma|April 10, 2008
Current treatment approaches for diffuse large B-cell lymphomaTim Illidge, Shaun Tolan
Leukemia & Lymphoma|August 9, 2005
Anti-CD 40 monoclonal antibodyTom Geldart, Tim Illidge
Leukemia & Lymphoma|July 8, 2008
How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?Tim Illidge, Clara Chan
The Journal of Pharmacy and Pharmacology|July 23, 2008
New insights into the mechanisms of action of radioimmunotherapy in lymphomaAndrei Ivanov, Ruth Swann, Tim Illidge
The New England Journal of Medicine|July 23, 2015
PET-Directed Therapy for Hodgkin's LymphomaJohn Radford, Tim Illidge, Sally Barrington
Current Opinion in Urology|August 24, 2016
Immunotherapy with radiotherapy in urological malignanciesShaveta Mehta, Tim Illidge, Ananya Choudhury
Pageof 7